 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 12 of 12 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Bezprozvanny I. on NEWS: First Crystal Structure of a Presenilin, The paper by Li et al. is a real tour de force that offers the first atomic resolution... 26 Dec 2012.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on PAPER: Chakroborty S. et al., 2012, In her previous series of papers, Dr. Stutzmann reported a number of
abnormalities in calcium... 10 Jul 2012.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on PAPER: Demuro A. et al., 2011, This is an elegant paper that uses the “optical patch clamp” method to resolve individual... 26 Oct 2011.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on PAPER: Yao CK. et al., 2009, This is a very interesting basic science paper for people who focus on synaptic vesicle turnover... 11 Sep 2009.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on NEWS: Presenilins, Ryanodine Receptors—Conspirators in Neurotransmission?, A number of previous studies indicated that FAD mutations and genetic deletions of presenilins... 5 Aug 2009.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on NEWS: Perpetrator and Savior—Presenilins Cut Both Ways, The paper by Tabuchi at al. is a fascinating study that uses genetic approach to investigate the... 5 Jun 2009.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on PAPER: Calcraft PJ. et al., 2009, It is well established that most of intracellular Ca2+ is stored in the endoplasmic reticulum... 27 Apr 2009.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on PAPER: Dreses-Werringloer U. et al., 2008, Amyloid-calcium Connection Is Getting More Intimate
The recent paper by Ute... 29 Jun 2008.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on PAPER: Cheung KH. et al., 2008, A number of previous reports linked FAD-causing mutations in presenilins with abnormal... 28 Jun 2008.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on LIVE DISCUSSION: Presenilin Loss of Function—Plan B for AD?, Loss of presenilin function and abnormal calcium signaling
The papers discussed... 2 Feb 2007.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on NEWS: Presenilins Open Escape Hatch for ER Calcium, Reply to Giuliano Binetti, Cristina Fasolato, Roberta Ghidoni, Paola Pizzo, and Sandro... 27 Sep 2006.
|
 |
 |
 |
 |
 |
Bezprozvanny I. on PAPER: Smith IF. et al., 2005 Sep-Oct, Very nice overview of recent data showing correlation between presenilin mutations and abnormal... 11 Sep 2006.
|
 |
 |
 |
 |
 |
 |
1 to 12 of 12 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |